SEC Filing Summary: Landec Corporation (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Landec Corporation (not Lifecore Biomedical, Inc.) on July 30, 2019. The report announces the issuance of a press release detailing consolidated financial results for the fourth quarter and the full fiscal year ended May 26, 2019.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These figures are contained within the referenced press release (Exhibit 99.1), which is furnished but not included in the text of this 8-K summary.
Material Changes
No specific material changes or comparative financial data are detailed in the body of this filing. The document serves solely as a notification that the results for the fourth quarter and full fiscal year 2019 have been released.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of unusual items. It explicitly states that the information in the press release is furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act.
Investor Verification Checklist
- Verify the correct registrant name is Landec Corporation (Ticker: LNDC), as the input metadata incorrectly referenced Lifecore Biomedical, Inc.
- Review Exhibit 99.1 (the press release) to obtain actual financial figures for Q4 and FY 2019.
- Confirm the fiscal year end date of May 26, 2019 when comparing to prior periods.
- Note that the financial data in the press release is not incorporated by reference into this specific 8-K filing.